These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 11600574)

  • 1. Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms.
    McTernan CL; Draper N; Nicholson H; Chalder SM; Driver P; Hewison M; Kilby MD; Stewart PM
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4979-83. PubMed ID: 11600574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth Restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery.
    Dy J; Guan H; Sampath-Kumar R; Richardson BS; Yang K
    Placenta; 2008 Feb; 29(2):193-200. PubMed ID: 18061258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction.
    Shams M; Kilby MD; Somerset DA; Howie AJ; Gupta A; Wood PJ; Afnan M; Stewart PM
    Hum Reprod; 1998 Apr; 13(4):799-804. PubMed ID: 9619527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression and activity of 11beta-hydroxysteroid dehydrogenase in human placenta and fetal membranes from pregnancies with intrauterine growth restriction.
    Wächter R; Masarik L; Bürzle M; Mallik A; von Mandach U
    Fetal Diagn Ther; 2009; 25(3):328-35. PubMed ID: 19776596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased gene expression of 11beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase in human placenta of patients with preeclampsia.
    Schoof E; Girstl M; Frobenius W; Kirschbaum M; Dörr HG; Rascher W; Dötsch J
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1313-7. PubMed ID: 11238526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression patterns of the 11β-hydroxysteroid dehydrogenase 2 enzyme in human placenta from intrauterine growth restriction: the role of impaired feto-maternal glucocorticoid metabolism.
    Börzsönyi B; Demendi C; Pajor A; Rigó J; Marosi K; Agota A; Nagy ZB; Joó JG
    Eur J Obstet Gynecol Reprod Biol; 2012 Mar; 161(1):12-7. PubMed ID: 22239940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11beta-hydroxysteroid dehydrogenase type 2 is the predominant isozyme in the guinea pig placenta: decreases in messenger ribonucleic acid and activity at term.
    Sampath-Kumar R; Matthews SG; Yang K
    Biol Reprod; 1998 Dec; 59(6):1378-84. PubMed ID: 9828181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of placental 11beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase mRNA expression during human gestation.
    Schoof E; Girstl M; Frobenius W; Kirschbaum M; Repp R; Knerr I; Rascher W; Dötsch J
    Eur J Endocrinol; 2001 Aug; 145(2):187-92. PubMed ID: 11454515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced 11beta-hydroxysteroid dehydrogenase type 2 activity is associated with decreased birth weight centile in pregnancies complicated by asthma.
    Murphy VE; Zakar T; Smith R; Giles WB; Gibson PG; Clifton VL
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1660-8. PubMed ID: 11932298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of restriction of placental and fetal growth on expression of 11beta-hydroxysteroid dehydrogenase type 1 and type 2 messenger ribonucleic acid in the liver, kidney, and adrenal of the sheep fetus.
    McMillen IC; Warnes KE; Adams MB; Robinson JS; Owens JA; Coulter CL
    Endocrinology; 2000 Feb; 141(2):539-43. PubMed ID: 10650933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia blocks 11beta-hydroxysteroid dehydrogenase type 2 induction in human trophoblast cells during differentiation by a time-dependent mechanism that involves both translation and transcription.
    Homan A; Guan H; Hardy DB; Gratton RJ; Yang K
    Placenta; 2006 Aug; 27(8):832-40. PubMed ID: 16271275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11Beta-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human placenta.
    Hirasawa G; Takeyama J; Sasano H; Fukushima K; Suzuki T; Muramatu Y; Darnel AD; Kaneko C; Hiwatashi N; Toyota T; Nagura H; Krozowski ZS
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1306-9. PubMed ID: 10720080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pro-inflammatory cytokines on expression and activity of 11beta-hydroxysteroid dehydrogenase type 2 in cultured human term placental trophoblast and human choriocarcinoma JEG-3 cells.
    Chisaka H; Johnstone JF; Premyslova M; Manduch Z; Challis JR
    J Soc Gynecol Investig; 2005 Jul; 12(5):303-9. PubMed ID: 15979541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by progesterone, estrogen, and the cyclic adenosine 5'-monophosphate pathway in cultured human placental and chorionic trophoblasts.
    Sun K; Yang K; Challis JR
    Biol Reprod; 1998 Jun; 58(6):1379-84. PubMed ID: 9623596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming.
    Seckl JR; Cleasby M; Nyirenda MJ
    Kidney Int; 2000 Apr; 57(4):1412-7. PubMed ID: 10760076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor delta suppresses 11beta-hydroxysteroid dehydrogenase type 2 gene expression in human placental trophoblast cells.
    Julan L; Guan H; van Beek JP; Yang K
    Endocrinology; 2005 Mar; 146(3):1482-90. PubMed ID: 15591138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental 11 beta-hydroxysteroid dehydrogenase-2 and fetal cortisol/cortisone shuttle in small preterm infants.
    Kajantie E; Dunkel L; Turpeinen U; Stenman UH; Wood PJ; Nuutila M; Andersson S
    J Clin Endocrinol Metab; 2003 Jan; 88(1):493-500. PubMed ID: 12519895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foetal and placental 11β-HSD2: a hub for developmental programming.
    Cottrell EC; Seckl JR; Holmes MC; Wyrwoll CS
    Acta Physiol (Oxf); 2014 Feb; 210(2):288-95. PubMed ID: 24330050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids, feto-placental 11 beta-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease.
    Seckl JR
    Steroids; 1997 Jan; 62(1):89-94. PubMed ID: 9029721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 and 2 in human placentas of term pregnancies according to birth weight and gender.
    Mericq V; Medina P; Kakarieka E; Márquez L; Johnson MC; Iñiguez G
    Eur J Endocrinol; 2009 Sep; 161(3):419-25. PubMed ID: 19542242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.